Single-step purification of equine chorionic gonadotrophin directly from plasma using affinity chromatography.

The research article discusses the development of an affinity chromatographic matrix, which is used to purify equine chorionic gonadotrophin (eCG) directly from plasma without any pre-treatment, increasing efficiency and yield.

Understanding Equine Chorionic Gonadotrophin

• Equine chorionic gonadotrophin (eCG) is a hormone that is primarily used in superovulation protocols due to its follicle-stimulating action. This hormone aids in enhancing the reproductive efficiency in animals of productive interest.
• eCG contains 45% carbohydrate, and 10% of this composition is N-acetylneuraminic acid, also known as sialic acid.
• The current purification processes used for eCG from equine serum or plasma largely depend on chromatographic methods. However, before these methods can be implemented, it is crucial to follow several sample pre-conditioning steps like different levels of precipitation stages and/or ultrafiltration/diafiltration processes.

Development of Affinity Chromatographic Matrix

• The researchers in the study aimed to create an effective affinity chromatographic matrix that could purify eCG directly from plasma without needing any kind of pre-treatment.
• The matrix created consisted of mini-spheres of chitosan with immobilized wheat germ agglutinin (WGA).
• This new matrix was capable of adsorbing about 98% of eCG directly from plasma without any pre-conditioning, with an overall yield of approximately 60%. The matrix chosen was also able to maintain this level of efficiency for three consecutive cycles.

Implications and Potential Application

• The process using the new matrix was scaled up 500 times in volume and tested over seven consecutive cycles, and it still maintained its chromatographic performance. This suggests that the process is stable and viable for scale-up.
• The results of this research indicate a potential application of this newly developed matrix for the one-step purification of eCG from plasma. This could result in substantial improvements in efficiency, and potentially reduce the cost and time of purification processes for eCG, which may have significant implications for its use in veterinary and animal breeding applications.